TGFBI and cancer: After analyzing the promoter methylation profile of long-term trastuzumab-sensitive and trastuzumab-resistant models developed in our laboratory [16, 17], three different methylated genes (TGFBI, CXCL2, and SLC38A1) implicated in cancer were identified and subsequently validated using different methylation and expression approaches.